February 1, 2021
BWXT Names Nuclear Medicine Business as BWXT Medical
LYNCHBURG, Va.–(BUSINESS WIRE)–BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company,…
Pharmaceuticals, Biotechnology and Life Sciences
LYNCHBURG, Va.–(BUSINESS WIRE)–BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company,…
LYNCHBURG, Va.–(BUSINESS WIRE)–BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company,…
SQZ AACs generated from red blood cells are designed to leverage a patient’s professional antigen-presenters to drive T cells to…
Opinion Granted Based on Significant Progression-Free Survival Benefit Demonstrated With KEYTRUDA Monotherapy Compared to Brentuximab Vedotin in Pivotal Phase 3…
Opinion Granted Based on Significant Progression-Free Survival Benefit Demonstrated With KEYTRUDA Monotherapy Compared to Brentuximab Vedotin in Pivotal Phase 3…
Opinion Granted Based on Significant Progression-Free Survival Benefit Demonstrated With KEYTRUDA Monotherapy Compared to Brentuximab Vedotin in Pivotal Phase 3…
FOSTER CITY, Calif. & EMERYVILLE, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology…
With new market authorization, Tilray confirms its development in the international medical cannabis sector and its leadership position in the…
With new market authorization, Tilray confirms its development in the international medical cannabis sector and its leadership position in the…
FOSTER CITY, Calif. & EMERYVILLE, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology…